New pain therapy ActiPatch launches in CARE Pharmacies
BioElectronics earlier this month launched its ActiPatch musculoskeletal pain therapy medical device through the regional chain CARE Pharmacies.
“With the current opioid crisis here in the United States, as pharmacists, we are delighted to be able to address the dire need for a safe over-the-counter alternative to opioids. Our focused pain consultations will enhance our patients’ relationships,” Mark Ey, vice president operations at CARE, said. “Providing therapeutic patient care is what we are trained to do.”
Pain sufferers and their physicians and pharmacists dramatically need an alternative first line therapy for pain. “We look forward to working with the CARE Pharmacies’ pharmacists to provide better safer patient care,” said Keith Nalepka, vice president sales and marketing at the Frederick, Md.-based BioElectronics.
New research shows that pain persists because the nerves have “learned” pain. When this happens, the body becomes highly sensitive to pain signals that do not go away even after the injury has healed. ActiPatch’s technology, first introduced into the U.S. market last year, reaches deep into the painful area to safely disrupt the abnormal pain signals, the company noted.
“With the current opioid crisis here in the United States, as pharmacists, we are delighted to be able to address the dire need for a safe over-the-counter alternative to opioids. Our focused pain consultations will enhance our patients’ relationships,” Mark Ey, vice president operations at CARE, said. “Providing therapeutic patient care is what we are trained to do.”
"With the current opioid crisis here in the United States, as pharmacists, we are delighted to be able to address the dire need for a safe over-the-counter alternative to opioids."
Pain sufferers and their physicians and pharmacists dramatically need an alternative first line therapy for pain. “We look forward to working with the CARE Pharmacies’ pharmacists to provide better safer patient care,” said Keith Nalepka, vice president sales and marketing at the Frederick, Md.-based BioElectronics.
New research shows that pain persists because the nerves have “learned” pain. When this happens, the body becomes highly sensitive to pain signals that do not go away even after the injury has healed. ActiPatch’s technology, first introduced into the U.S. market last year, reaches deep into the painful area to safely disrupt the abnormal pain signals, the company noted.